🔎 Trials Near Me

Home › Cerebral Hemorrhage › NCT07651631

Rapid Evacuation and Access of Cerebral Hemorrhage Registry

RecruitingObservational study

A Prospective, Multicenter, Global Registry Evaluating Minimally Invasive Surgery for the Treatment of Acute Spontaneous Supratentorial Intracerebral Hemorrhage.

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage
* Hemorrhage volume ≥ 20 mLs
* Minimally invasive surgical intervention performed within 7 days of hemorrhage

Exclusion Criteria:

* Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (\<1 year), as diagnosed with radiographic imaging
* Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum
* Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms
* Last known normal is unknown
* Historical Modified Rankin Score \> 4
* Known life-expectancy of less than 1 year prior to ICH
* DNR or comfort measures only
* Known pregnancy in female subjects
* Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival
* Inability to meet follow up requiremen

About the study

The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.

Sponsor: Emory University · Participants: 2,500 · Started: Aug 12, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07651631

Locations in the U.S.

GeorgiaGrady Memorial Hospital, Atlanta

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.